Cargando…

A Novel Mechanism Is Involved in Cationic Lipid-Mediated Functional siRNA Delivery

[Image: see text] A key challenge for therapeutic application of RNA interference is to efficiently deliver synthetic small interfering RNAs (siRNAs) into target cells that will lead to the knockdown of the target transcript (functional siRNA delivery). To facilitate rational development of nonviral...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, James J., Langer, Robert, Chen, Jianzhu
Formato: Texto
Lenguaje:English
Publicado: American Chemical Society 2009
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2688906/
https://www.ncbi.nlm.nih.gov/pubmed/19292453
http://dx.doi.org/10.1021/mp900023v
_version_ 1782167737058983936
author Lu, James J.
Langer, Robert
Chen, Jianzhu
author_facet Lu, James J.
Langer, Robert
Chen, Jianzhu
author_sort Lu, James J.
collection PubMed
description [Image: see text] A key challenge for therapeutic application of RNA interference is to efficiently deliver synthetic small interfering RNAs (siRNAs) into target cells that will lead to the knockdown of the target transcript (functional siRNA delivery). To facilitate rational development of nonviral carriers, we have investigated by imaging, pharmacological and genetic approaches the mechanisms by which a cationic lipid carrier mediates siRNA delivery into mammalian cells. We show that ∼95% of siRNA lipoplexes enter the cells through endocytosis and persist in endolysosomes for a prolonged period of time. However, inhibition of clathrin-, caveolin-, or lipid-raft-mediated endocytosis or macropinocytosis fails to inhibit the knockdown of the target transcript. In contrast, depletion of cholesterol from the plasma membrane has little effect on the cellular uptake of siRNA lipoplexes, but it abolishes the target transcript knockdown. Furthermore, functional siRNA delivery occurs within a few hours and is gradually inhibited by lowering temperatures. These results demonstrate that although endocytosis is responsible for the majority of cellular uptake of siRNA lipoplexes, a minor pathway, probably mediated by fusion between siRNA lipoplexes and the plasma membrane, is responsible for the functional siRNA delivery. Our findings suggest possible directions for improving functional siRNA delivery by cationic lipids.
format Text
id pubmed-2688906
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-26889062009-06-01 A Novel Mechanism Is Involved in Cationic Lipid-Mediated Functional siRNA Delivery Lu, James J. Langer, Robert Chen, Jianzhu Mol Pharm [Image: see text] A key challenge for therapeutic application of RNA interference is to efficiently deliver synthetic small interfering RNAs (siRNAs) into target cells that will lead to the knockdown of the target transcript (functional siRNA delivery). To facilitate rational development of nonviral carriers, we have investigated by imaging, pharmacological and genetic approaches the mechanisms by which a cationic lipid carrier mediates siRNA delivery into mammalian cells. We show that ∼95% of siRNA lipoplexes enter the cells through endocytosis and persist in endolysosomes for a prolonged period of time. However, inhibition of clathrin-, caveolin-, or lipid-raft-mediated endocytosis or macropinocytosis fails to inhibit the knockdown of the target transcript. In contrast, depletion of cholesterol from the plasma membrane has little effect on the cellular uptake of siRNA lipoplexes, but it abolishes the target transcript knockdown. Furthermore, functional siRNA delivery occurs within a few hours and is gradually inhibited by lowering temperatures. These results demonstrate that although endocytosis is responsible for the majority of cellular uptake of siRNA lipoplexes, a minor pathway, probably mediated by fusion between siRNA lipoplexes and the plasma membrane, is responsible for the functional siRNA delivery. Our findings suggest possible directions for improving functional siRNA delivery by cationic lipids. American Chemical Society 2009-03-17 2009-06-01 /pmc/articles/PMC2688906/ /pubmed/19292453 http://dx.doi.org/10.1021/mp900023v Text en Copyright © 2009 American Chemical Society http://pubs.acs.org This is an open-access article distributed under the ACS AuthorChoice Terms & Conditions. Any use of this article, must conform to the terms of that license which are available at http://pubs.acs.org.
spellingShingle Lu, James J.
Langer, Robert
Chen, Jianzhu
A Novel Mechanism Is Involved in Cationic Lipid-Mediated Functional siRNA Delivery
title A Novel Mechanism Is Involved in Cationic Lipid-Mediated Functional siRNA Delivery
title_full A Novel Mechanism Is Involved in Cationic Lipid-Mediated Functional siRNA Delivery
title_fullStr A Novel Mechanism Is Involved in Cationic Lipid-Mediated Functional siRNA Delivery
title_full_unstemmed A Novel Mechanism Is Involved in Cationic Lipid-Mediated Functional siRNA Delivery
title_short A Novel Mechanism Is Involved in Cationic Lipid-Mediated Functional siRNA Delivery
title_sort novel mechanism is involved in cationic lipid-mediated functional sirna delivery
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2688906/
https://www.ncbi.nlm.nih.gov/pubmed/19292453
http://dx.doi.org/10.1021/mp900023v
work_keys_str_mv AT lujamesj anovelmechanismisinvolvedincationiclipidmediatedfunctionalsirnadelivery
AT langerrobert anovelmechanismisinvolvedincationiclipidmediatedfunctionalsirnadelivery
AT chenjianzhu anovelmechanismisinvolvedincationiclipidmediatedfunctionalsirnadelivery
AT lujamesj novelmechanismisinvolvedincationiclipidmediatedfunctionalsirnadelivery
AT langerrobert novelmechanismisinvolvedincationiclipidmediatedfunctionalsirnadelivery
AT chenjianzhu novelmechanismisinvolvedincationiclipidmediatedfunctionalsirnadelivery